Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : InvestRight - Short Term Trading St -- Ignore unavailable to you. Want to Upgrade?

To: rebecca who wrote (141)	9/13/1998 10:47:00 PM
From: Jeffrey L. Henken	Respond to of 939

>Regarding biotechs, it is certainly clear that a rally has began in the 2nd and 3rd tier biotechs such as cnto, bgen , sepr and medi. Jeff, any technical assessements on any of these issues??< CNTO is a buy, but it is overbought. Look for support around 34.22 and buy on any pull back as long as it does not break through support. SEPR has recently deteriorated to the extent that it fell through support and it is recommended that longs should close their positions. It needs to get back over 51.30 and close there on high volume before it should be considered a safe buy on a strictly technical basis. BGEN has a neutral rating and MEDI is an avoid. I check all these at Market Edge's Second Opinion. InvestRight Regards, Jeff

To: rebecca who wrote (141)	9/13/1998 11:31:00 PM
From: mike mulhearn	Respond to of 939

I was going to comment, but forget it Hehehe.

To: rebecca who wrote (141)	10/17/1998 11:03:00 PM
From: Jeffrey L. Henken	Respond to of 939

Hey rebecca, I think it's time to take another look at EVDS. This is not your typical start up company in that sales of the CAPSCAN could make the company highly profitable before the end of the year. Check out this chart and notice that the last few days the stock is showing some accumulation as the spread tightens: dailystocks.net This could indicate that the stock is getting ready to move. As you know I have really done my homework on this one. If the CAPSCAN meets with the interest indicated by pre-orders then the stock is clearly undervalued at these levels. Check out the EVDS thread: Subject 22787 BTW how about that move on CCSI on Friday? Sometimes, life is good. Regards, Jeff